Advances, advances and more advances in Oncology. People, do you trust this statement? How do you feel when your doctor informs you that you have cancer?
Catalin Vlad; pp 1189-1193 (Pubmed Abstract, PDF)

Mutational landscape in uveal melanoma
Stylianos Mastronikolis, Maria Adamopoulou, Sotirios Papouliakos, Arezina Manoli, Spyros Katsinis, Olga Makri, Antonella-Effrosyni Monastirioti, Evangelos Tsiambas, Constantinos Georgakopoulos; pp 1194-1197 (Pubmed Abstract, PDF)

Classification, histopathology and molecular pathology of thymic epithelial tumors: a review
Christos Valavanis, Gabriela-Monica Stanc, Nikolaos Baltayiannis; pp 1198-1207 (Pubmed Abstract, PDF)

Oncologic outcomes after laparoscopic versus open resection for colorectal liver metastases
Dimitrios Moris; p 1208 (Pubmed Abstract, PDF)

Liver transplantation for unresectable colorectal liver metastases
Dimitrios Moris; pp 1209-1210 (Pubmed Abstract, PDF)

COLORECTAL CANCER

Down regulation of tumour biomarkers in colon cancer cells with IRNA PFK-1 plus metformin
Eduardo Alejandro Reyes-Serratos, Elisa Fernandez-Castillo, Lizeth Sanchez-Lopez, Mauricio Salinas-Santander, Danielle Annette Orozco-Nunnelly, Monica Gabriela Sanchez-Salazar, Enrique Cervantes-Astorga, Ana Maria Rivas-Estilla, Clara Patricia Rios-Ibarra; pp 1210-1218 (Pubmed Abstract, PDF)

Atorvastatin inhibits proliferation and promotes apoptosis of colon cancer cells via COX-2/PGE2/β-Catenin Pathway
Shuyan Cai, Zhigang Gao; pp 1219-1225 (Pubmed Abstract, PDF)

Diagnostic value of combined detection of multiple tumor markers and blood lipid indexes in colorectal cancer and its prediction on adverse reactions of chemotherapy
Mingzhe Jiang, Guowei Ding, Guozhong Li; pp 1226-1230 (Pubmed Abstract, PDF)

A comparison of dosimetric and clinical parameters between different IMRT boost techniques in preoperative rectal cancer
Sibel Karaca, Kadriye Aysenur Arli Karacam; pp 1231-1238 (Pubmed Abstract, PDF)

Highly sensitive fecal DNA testing of NDRG4 12b methylation is a promising marker for detection of colorectal precancerosis
Xiaofeng Ji, Jie Sha, Haisheng Qian, Guoxin Zhang, TiHe4, Yini Dang; pp 1239-1245 (Pubmed Abstract, PDF)

RNF38 enhances 5-Fluorouracil resistance in CRC by activating the Wnt pathway
Yaxin Long, Quan Zhao, Yingguang Huang; pp 1246-1251 (Pubmed Abstract, PDF)

Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma
Fuqiang Zhao, Yanlong Liu, Xinyue Gu, Bomiao Zhang, Chengxin Song, Binbin Cui; pp 1252-1259 (Pubmed Abstract, PDF)

Mitomycin-C versus oxaliplatin during cytoreductive surgery and HIPEC for peritoneal metastases secondary to colorectal carcinoma: a retrospective analysis
John Spiliotis, Vasileios Kalles, Anastasia Prodromidou, Apostolos Raptis, Marios Ferfelis, Athina Christopoulou, Marios Tsiatas; pp 1260-1265 (Pubmed Abstract, PDF)

Quality of life deterioration and colorectal cancer staging in elderly patients. Which comes first?
Alexandros Diamantis, Georgios Tzovaras, Athina Samara, Dimitrios Magouliotis, Ioannis Baloyiannis, Dimitrios Symeonidis, Eleni Arnaoutoglou, Konstantinos Tepetes; pp 1266-1270 (Pubmed Abstract, PDF)

GYNECOLOGIC CANCERS

Bevacizumab in recurrent ovarian cancer
Mehmet Sait Bakir, Ozer Birge, Ceyda Karadag, Yusuf Ilhan, Hasan Aykut Tuncer, Sema Sezgin Göksu, Tayup Simsek; pp 1271-1278 (Pubmed Abstract, PDF)

FTO-stabilized lncRNA HOXC13-AS epigenetically upregulated FZD6 and activated Wnt/β-catenin signaling to drive cervical cancer proliferation, invasion, and EMT
Tongfei Wang, Weina Li, Biaofei Ye, Shuangyan Zhang, Xin Lei, Da Zhang; pp 1279-1291 (Pubmed Abstract, PDF)

Development of a CAUTI risk factor evaluation index system for postoperative patients with gynecological malignant tumors
Chunlan Wang, Xia Shen, Jin Huang, Liyao Xia, Hemei Wang; pp 1292-1297 (Pubmed Abstract, PDF)

Efficacy of helical tomotherapy combined with CT-guided three-dimensional intracavitary brachytherapy in treatment of locally advanced cervical cancer
Xiabin Ye, Pengsong Ye, Yanfang Zheng, Weilan Xia; pp 1298-1305 (Pubmed Abstract, PDF)

Neoadjuvant chemotherapy combined with laparoscopic cytoreductive surgery in patients with advanced ovarian cancer
Aiping Wen, Lei Zhao, Le Luo, Chengchao Du, Xin Luo; pp 1306-1312 (Pubmed Abstract, PDF)

Impact of combined mycoplasmataceae and HPV co-infection on females with cervical intraepithelial neoplasia and carcinoma
Maria Adamopoulou, Dimitrios Avgoustidis, Chrysa Voyiatjaki, Apostolos Beloukas, Christos Yapijakis, Evangelos Tsiambas, Ekatherina Charvalos; pp 1313-1319 (Pubmed Abstract, PDF)

Curative effect of hyperfractionated accelerated radiotherapy combined with EP chemotherapy regimen on limited-stage small cell lung cancer
Yeru Tan, Qiao Yang, Xiaoping Wu, Hongbo Zhu; pp 1320-1326 (Pubmed Abstract, PDF)

Expression of Delta Like Ligand 4 (DLL4) in endometrial carcinomas and tumor vasculature
Zacharias Fasoulakis, Georgios Galazios, Michail Koukourakis, Nikolaos Nikolettos, Alexandra Giatromanolaki, Michail Pitiakoudis, Nikoleta Koutlaki, Emmanuel N.Kontomanolis; pp 1327-1332 (Pubmed Abstract, PDF)

LIVER CANCER

FBXL19-AS1 aggravates the progression of hepatocellular cancer by downregulating KLF2
Yudan Chen, Linglin Yang; pp 1333-1339 (Pubmed Abstract, PDF)

Expression of miR-187 and miR-509-3p in serum of primary hepatocellular carcinoma patients and its evaluation of prognosis
Guisen Dai, Shaoxin Shen, Yongsheng Liu, Xijing Ma, Yingbing Fang, Yixin Weng, Chunying Li; pp 1340-1345 (Pubmed Abstract, PDF)

Predictive value of and relationship between the gamma-glutamyl transpeptidase to lymphocyte ratio and CT features in hepatocellular carcinoma patients with postoperative adjuvant TACE
Hui Zhao, Xiaokan Liu, Ruonan Xu, Xiaoli Guo, Aiguo Shen; pp 1346-1354 (Pubmed Abstract, PDF)

Efficacy and safety of sorafenib combined with TACE in the treatment of advanced hepatocellular carcinoma: A meta-analysis
Dailong Li, Yaqi Pang, Lu Xu, Xinhua Xu; pp 1355-1364 (Pubmed Abstract, PDF)

Human β-defensin 1 Functions as a Tumor Suppressor via ER Stress-triggered JNK pathway in Hepatocellular Carcinoma
Xinhong Li, Wanying Song, Mingyu Zhang, Pengwei Zhao; pp 1365-1372 (Pubmed Abstract, PDF)

Three-dimensional DSA guidance reduces complications and enhances the safety during interventional treatment for patients with hepatocellular carcinoma
Renjie Li, Fuqiang Zhang; pp 1373-1378 (Pubmed Abstract, PDF)

BREAST CANCER

The reliability of breast cancer surgery in a regional pandemic hospital during the COVID-19 pandemic: Delay or Do?
Umit Turan, Ali Kaan Sanal, Oktay Irkorucu; pp 1379-1385 (Pubmed Abstract, PDF)

Nomograms predicting overall survival and cancer-specific survival in metaplastic breast cancer patients
Huawei Shi, Linfeng Yu, Jiyuan Mai, Ping Zhang, Kun Fang; pp 1386-1397 (Pubmed Abstract, PDF)

Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data
Ozturk Ates, O. Berna Oksuzoglu, Burak Yasin Aktas, Ibrahim Karadag, Selin Esen, Serdar Karakaya, Dogan Uncu3, Cihan Erol, Mustafa Gurbuz, Bulent Yalcin, Sercan Aksoy; pp 1398-1404 (Pubmed Abstract, PDF)

The new normal for breast cancer surgery during COVID-19 pandemic: An international survey conducted by SENATURK
Nuh Zafer Canturk, Sertac Ata Guler, Mehmet Ali Kocdor, Turgay Simsek; pp 1405-1414 (Pubmed Abstract, PDF)

Analysis of risk factors related to breast cancer metastasis: a retrospective nested case-control study
Yang Liu, Bin Liu, Yang He, Zhijun Li, Xinwei Li, Duo Wang, Zongqiang Wang, Ying Xu, Qiong Yu; pp 1415-1421 (Pubmed Abstract, PDF)

LUNG CANCER

Let-7a targets Rsf-1 to modulate radiotherapy response of non-small cell lung cancer cells through Ras-MAPK pathway
Zhenliang Shi, Jia Liu, Daqiang Sun; pp 1422-1431 (Pubmed Abstract, PDF)

Application effect of dexmedetomidine combined with flurbiprofen axetil and flurbiprofen axetil monotherapy in radical operation of lung cancer and evaluation of the immune function
Shilan Zong, Jianguo Du, Yuanyuan Chen, Hong Tao; pp 1432-1439 (Pubmed Abstract, PDF)

Clinical significance of detecting HDL and miR-103 levels in lung carcinoma patients
Yan Zhang, Xinhong Zhang, Zhihai Han; pp 1440-1445 (Pubmed Abstract, PDF)

Upfront thoracic radiotherapy to primary lesion improves outcomes in patients with stage IV non-small cell lung cancer harboring EGFR mutations
Ayse Kotek Sedef, Berna Akkus Yildirim, Erkan Topkan, Ahmet Taner Sumbul; pp 1446-1452 (Pubmed Abstract, PDF)

Short- and medium-term outcomes after uniportal and multiportal video-assisted thoracic surgery lobectomy in elderly patients with non-small cell lung cancer
Dian Zhong, Qing Lin, Jinqiang Zhang, Yujuan Liu, Zhiqiang Zhan; pp 1453-1459 (Pubmed Abstract, PDF)

GASTRIC CANCER

Influences of lncRNA HEIH and DKK3 on the clinical features and prognosis of gastric cancer
Hui Dong, Fengjie Li, Aichun Jin; pp 1460-1465 (Pubmed Abstract, PDF)

Clinical and pathological significance of proliferation index and p53 expression in gastric adenocarcinoma
Miljan Zindovic, Milena Vuletic, Sanja Milenkovic, Snezana Jancic, Miljan Krstic, Dunja Zindovic, Velimir Milosevic; pp 1466-1478 (Pubmed Abstract, PDF)

Effects of MSCT enhanced scan image diagnosis on clinical outcome of patients after radical gastrectomy and its influence on misdiagnosis rate
Dujuan Yang, Yeping Zhou, Zhengwei Peng, Nan Ou; pp 1479-1484 (Pubmed Abstract, PDF)

Efficacy of paclitaxel and S-1 combined with apatinib in the conversion therapy for unresectable advanced gastric cancer
Zhongping Wu, Haixing Fang; pp 1485-1490 (Pubmed Abstract, PDF)

BLADDER CANCER

Circ_0006948 drives the malignant development of bladder cancer via activating the epithelial-mesenchymal transition
Fei Liu, Ninghua Wang, Jun Wei, Mei Xue, Yu Liu, Rui Dong; pp 1491-1497 (Pubmed Abstract, PDF)

Biological functions of miR-363-3p/BTG2 in the metastasis of bladder cancer
Peng Li, Yizhi Yu, Xiaofei Wang, Keyao Hu, Yuhang Wang, Fengguang Li, Haiying Zhang; pp 1498-1503 (Pubmed Abstract, PDF)

Diagnostic and prognostic potentials of AK126393 in bladder cancer
Yawei Guan, Guohui Zhang, Zhihui Li, Xin Ai, Zhuomin Jia, Jingfei Teng; pp 1504-1508 (Pubmed Abstract, PDF)

ESOPHAGEAL CANCER

Chemoradiotherapy followed by surgery versus observation in esophageal squamous cell carcinoma
Abdullah Sakin, Suleyman Sahin,Mehmet Naci Aldemir, Umit Haluk Iliklerden, Mehmet Cetin Kotan; pp 1509-1516 (Pubmed Abstract, PDF)

MANCR drives esophageal carcinoma progression by targeting PDE4D
Jingxian Fan, Fanlin Wang; pp 1517-1522 (Pubmed Abstract, PDF)

Results of upfront surgery in a mixed stage population of patients with esophageal carcinoma: early outcome and long term survival
Christos Prokakis, Marianna Maliouki, Efstratios Koletsis, Kapezanos Athanasios, Antonios Chatzimichalis, Nikolaos Baltayiannis, Nikolaos Charokopos, Konstantinos Thomopoulos, Konstantinos Dougenis; pp 1523-1529 (Pubmed Abstract, PDF)

HEMATOLOGIC MALIGNANCIES

TP73-AS1 promotes malignant progression of NK/T cell lymphoma by regulating DKK1 methylation
Hui Zhang, Qianqian Huang; pp 1530-1535 (Pubmed Abstract, PDF)

Pralatrexate experience in PTCL: A multicenter retrospective study from Turkey
Mehmet Sinan Dal , Alparslan Merdin, Mehmet Ali Erkurt, Ömer Ekinci, Murat Albayrak, Sibel Kabukcu Hacioglu, Ayse Kaya, Mehmet Hilmi Dogu, Fehmi Hindilerden, Ahmet Sarici, Mustafa Merter, Merih Reis Aras, Gulsum Akgun Caglıyan, Merih Kizil Cakar, Ismet Aydogdu, Irfan Kuku, Serdal Korkmaz, Turgay Ulas, Bulent Eser, Fevzi Altuntas; pp 1536-1539 (Pubmed Abstract, PDF)

Targeted massively parallel sequencing in the management of cytogenetically normal lymphoid malignancies
Emine Ikbal Atli, Hakan Gurkan, Engin Atli, Sinem Yalcintepe, Selma Demir, Damla Eker, Rasime Kalkan, Ahmet Muzaffer Demir; 1540-1548 (Pubmed Abstract, PDF)

CNS TUMORS

Effects of triptolide on radiosensitivity of human glioma cells and its mechanism
Mengting Shu, Chenguang Li, Chen Zhong, Tongyi Huang, Xinzhuang Wang, Yang Tan, Wenyang Zhao, Xiaoyan Xie; pp 1549-1555 (Pubmed Abstract, PDF)

METTL3 participates in glioma development by regulating the methylation level of COL4A1
Jianguo Han, Shiwei Du, Chong Wu, Ming Qiu, Li Su, Zhijun Zhao, Si Cheng, Wei Tao;pp 1556-1562 (Pubmed Abstract, PDF)

HEAD & NECK CANCER

VASN promotes proliferation of laryngeal cancer cells via YAP/TAZ
Haotian Liu, Weili Kong, Shuxin Wen, Junhao Wu, Xiaoling Yin, Yuhe Liu; pp 1563-1570 (Pubmed Abstract, PDF)

Double isocenter optimization with HD-MLC linear accelerator to treat extended fields in patients with head and neck cancers
Yucel Saglam, Ugur Selek, Yasemin Bolukbasi, Ali Ihsan Atasoy, Fatih Karakose, Vildan Alpan, Eyub Yasar Akdemir, Sukran Senyurek, Nulifer Kilic Durankus, Duygu Sezen, Ahmet Kucuk, Erkan Topkan; pp 1571-1581 (Pubmed Abstract, PDF)

OSTEOSARCOMA

A potential diagnostic marker for osteosarcoma: hsa_circ_0005721
Ziyin Han, Zufang Mou, Yulong Jing, Rong Jiang, Tao Sun; pp 1582-1587 (Pubmed Abstract, PDF)

hsa_circ_0005721 triggers proliferation, migration and invasion of osteosarcoma by upregulating the linear transcript TEP1
Meixin Xu, Xingxia Sun, Yang Liu, Liang Chang, Hasi.te Wang, Shuren Wang; pp 1584-1598 (Pubmed Abstract, PDF)

PANCREATIC CANCER

The WNT5A/ROR2 signaling pathway in pancreatic ductal adenocarcinoma (PDAC)
Lydia Remtisch, Georg Wiltberger, Katrin Schierle, Moulla Yousef, René Thieme, Boris Jansen-Winkeln, Christian Wittekind, Ines Gockel, Orestis Lyros; pp 1595-1606 (Pubmed Abstract, PDF)

Pancreatic cancer patients who cannot undergo curative surgery live as much as patients over 70 years old
Yildirim Serkan, Erdogan Atike Pinar, Yilmaz Cengiz, Ozveren Ahmet, Ekinci Ferhat, Bulut Gulcan; pp 1607-1611 (Pubmed Abstract, PDF)

PROSTATE CANCER

A nomogram concerning immune infiltration and radiosensitivity to predict biochemical recurrence after radical radiation therapy in prostate cancer
Chunyan Qiu, Xingni Zhou, Zhijian Chen, Hua Ren; pp 1612-1622 (Pubmed Abstract, PDF)

ADAMTS9-AS2: a potential diagnostic and prognostic hallmark in prostate cancer
Lei He, Yin Xiao, Limin Ma, Fan Zhao, Tiannan Yu, Yeqing Huang; pp 1623-1627 (Pubmed Abstract, PDF)

RENAL CARCINOMA

Real-life data on first-line Sunitinib and Pazopanib therapy in metastatic renal cell carcinoma patients: a single center experience
Alper Topal, Sezin Sayın, Ali Gokyer, Ahmet Kucukarda, Osman Kostek, Muhammet Bekir Hacıoglu, Sernaz Uzunoglu, Bulent Erdogan, Irfan Cicin; pp 1628-1634 (Pubmed Abstract, PDF)

THYROID CANCER

Curcumin inhibits proliferation and invasion of papillary thyroid carcinoma cells by inhibiting the JAK2 / STAT3 pathway
Ying Hu, Ning Zhou, Qiongwen Zhu; pp 1635-1641 (Pubmed Abstract, PDF)

MISCELLANEOUS

Advanced germ cell tumors and chemotherapy in G6PD deficientpatients: Yes to chemotherapy but no to rasburicase and some premedications
Ioanna Gazouli, Dimitris Baltogiannis, Panagiotis Ntellas, Maria Smaragdi Vlachou, Christos Tagkas, Ioannis Champilomatis, Εleftherios Kampletsas, Maria Tolia, Davide Mauri; pp 1642-1646 (Pubmed Abstract, PDF)

Twenty-years’ experience with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) forpseudomyxoma peritonei (PMP).
Papantoni Evangelia, Ntatsis Konstantinos, Kyziridis Dimitrios, Kalakonas Apostolos, Hristakis Christos, Tentes Antonios-Apostolos; pp 1647-1652 (Pubmed Abstract, PDF)

Etiologies of remarkably elevated serum levels of carbohydrate antigen 19-9
Hui Zhang, Lei Jia, Youqing Xu; pp 1653-1658 (Pubmed Abstract, PDF)

The effect of COVID-19 on oncology practice in Turkey*
Ismail Beypinar; pp 1659-1662 (Pubmed Abstract, PDF)

Effects of varying statistical uncertainty using a Monte Carlo based treatment planning system for VMAT
Jacob Rembish, Pamela Myers, Daniel Saenz, Neil Kirby, Nikos Papanikolaou, and Sotirios Stathakis; pp 1663-1668 (Pubmed Abstract, PDF)

Cytoreductive surgery and HIPEC for peritoneal metastasis. Justified hope or desperate illusion? Fifteen years of experience from a Greek Peritoneal Surface Malignancy center
John Spiliotis, Nikolaos Kopanakis, Alexios Terra, Christos Iavazzo, Anastasia Prodromidou, Athanasios Rogdakis, Elias Efstathiou; pp 1669-1678 (Pubmed Abstract, PDF)

Differences in surgical oncology practice in Greece and Cyprus between the first and second COVID-19 pandemic waves: Lessons from a paradigm shift
Dimitrios Magouliotis, Maria Fergadi, Despoina Koukousaki, Dimitrios Symeonidis, Alexandros Diamantis, Evangelos Tatsios, Gregory Christodoulidis, Dimitris Zacharoulis; pp 1679-1682 (Pubmed Abstract, PDF)

Hormonal status might affect outcome in women with HER2-positive ductal carcinoma in situ treated with radiotherapy alone or concurrent radiotherapy plus trastuzumab
Kadri Altundag; p 1683 (Pubmed Abstract, PDF)

Telomerase activity in nasopharyngeal carcinoma
Spyros Katsinis, Arezina Manoli, Sotirios Papouliakos, Evangelos Tsiambas; p 1683 (Pubmed Abstract, PDF)

Synchronous metastases of infiltrating lobular breast carcinomato stomach and colon: ; rare but it does occur
Kadri Altundag; p 1684 (Pubmed Abstract, PDF)

What is the best time for 18F-FDG-PET evaluation in estrogen receptor-negative and HER2-positive breast cancer patients receiving neoadjuvant trastuzumab and pertuzumab?
Kadri Altundag; p 1685 (Pubmed Abstract, PDF)

C-myc oncogene activation in pharyngeal-esophageal squamous cell carcinoma
Dimitrios Tsounis, Evangelos Falidas, Antonella-Effrosyni Monastirioti, Evangelos Tsiambas; p 1686 (Pubmed Abstract, PDF)

Triple-negative breast cancer metastasizing to gingiva
Kadri Altundag; p 1687 (Pubmed Abstract, PDF)

Discordance rates in hormone receptor status between primary and metastatic sites might incluence clinical outcome in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy
Kadri Altundag; p 1687 (Pubmed Abstract, PDF)

SARS-CoV-2 infection in breast carcinoma patients
Athanasios Niotis, Konstantinos Manios, Odysseas Dimas, Evangelos Tsiambas; p 1688 (Pubmed Abstract, PDF)

Higher incidence of osteonecrosis of the jaw in patients with multiple myeloma receiving zoledronic acid: is there any rational explanation?
Kadri Altundag; p 1689 (Pubmed Abstract, PDF)

COVID-19 in pancreatic carcinoma patients
Dimitrios Tsounis, Loukas Manaios, Evangelos Tsiambas, Despoina Spyropoulou; pp 1689-1690 (Pubmed Abstract, PDF)

Retraction Note to: Acetylshikonin inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant oral cancer cells by inducing autophagy, programmed cell death and targeting m-TOR/PI3K/Akt signalling pathway
Peng Wang, Weiyue Gao, Yibin Wang, Jun Wang; p 1691 (Pubmed Abstract, PDF)

Retraction Note to: Anticancer effects of ovatodiolide on human prostate cancer cells involves cell cycle arrest, apoptosis and blocking of Ras/Raf/MEK/ERK signaling pathway
Dongsheng Jia, Jianbo Zheng, Junli Yu, Ning Zhao, Shengxing Lu, Dongfang Hao; p 1692 (Pubmed Abstract, PDF)

Retraction Note to: HHIP gene overexpression inhibits the growth, migration and invasion of human liver cancer cells
Xiaobin Wang, Wenjie Ma, Jun Yin, Meizhu Chen, Hong Jin; p 1693 (Pubmed Abstract, PDF)

Retraction Note to: Lycopsamine inhibits the proliferation of human lung cancer cells via induction of apoptosis and autophagy and suppression of interleukin-2.
Zhengang Yu, Guifang Guo, Bingzhe Wang; p 1694 (Pubmed Abstract, PDF)

Retraction Note to: MicroRNA-23 regulates the growth, metastasis and chemosensitivity of human gastric cancer cells by targeting MAP3K9
Deping Li, Juan Wang, Yuanjian Hui, Yan Yang, Xingchun Peng, Shengbao Li, Chuantao Sun; p 1695 (Pubmed Abstract, PDF)

Retraction Note to: Oridonin triggers G2/M cell cycle arrest, cellular apoptosis and autophagy in human gastric cancer cells
Dongliang Zhu, Xiaoling Tian, Xiaoping Yin, Haidong Yan, Weihao Li; p 1696 (Pubmed Abstract, PDF)

Retraction Note to: Dammarenediol suppresses the growth, migration and invasion of human osteosarcoma cells by modulating PI3K/Akt and STAT-3 signaling pathways
Yingbin Wu, Yue Chen, Zheng Xu, Ming Xiang; p 1697 (Pubmed Abstract, PDF)